Multiple Congenital Anomalies Associated with In Utero Exposure of Phenytoin: Possible Hypoxic Ischemic Mechanism?

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 67, Issue 12, 2003, Pages 993-996

  Lyon, Helen M ^a,b   Holmes, Lewis B ^c   Huang, Taosheng ^d  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYTOIN;

ALCOHOL CONSUMPTION; ARTICLE; BLOOD VESSEL INJURY; BRADYCARDIA; CASE REPORT; CIGARETTE SMOKING; CONGENITAL MALFORMATION; EPILEPSY; FACE MALFORMATION; FEMALE; FETOTOXICITY; FINGER MALFORMATION; FOOT MALFORMATION; HAND MALFORMATION; HUMAN; HYPOPLASIA; HYPOXIA; INFANT DISEASE; ISCHEMIA; MENINGOMYELOCELE; NEWBORN; PEDICLED SKIN FLAP; PES EQUINOVARUS; PHENOTYPE; PRENATAL DRUG EXPOSURE; PRENATAL EXPOSURE; PRIORITY JOURNAL; SYNDACTYLY; TERATOGENESIS;

ABNORMALITIES, DRUG-INDUCED; ABNORMALITIES, MULTIPLE; ADULT; ANOXIA; ANTICONVULSANTS; EPILEPSY; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; ISCHEMIA; MATERNAL EXPOSURE; PHENYTOIN; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 0345731423     PISSN: 15420752     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdra.10100     Document Type: Article

References (32)

1. Azarbayjani F, Danielsson BR. 2001. Phenytoin-induced cleft palate: evidence for embryonic cardiac bradyarrhythmia due to inhibition of delayed rectifier K+ channels resulting in hypoxia-reoxygenation damage. Teratology 63:152-160.
2. Barr M Jr, Poznanski AK, Schmickel RD. 1974. Digital hypoplasia and anticonvulsants during gestation: a teratogenic syndrome. J Pediatr 84:254-256.
3. Bertollini R, Kallen B, Mastroiacovo P, Robert E. 1987. Anticonvulsant drugs in monotherapy. Effect on the fetus. Eur J Epidemiol 3:164-171.
4. Buehler BA, Delimont D, van Waes M, Finnell RH. 1990. Prenatal prediction of risk of the fetal hydantoin syndrome. N Engl J Med 322:1567-1572.
5. Buehler BA, Rao V, Finnell RH. 1994. Biochemical and molecular teratology of fetal hydantoin syndrome. Neurol Clin 12:741-748.
6. Charlier C, Singh NA, Ryan SG, et al. 1998. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat Genet 18:53-55.
7. Clark KE, Irion GL. 1992. Fetal hemodynamic response to maternal intravenous nicotine administration. Am J Obstet Gynecol 167:1624-1631.
8. Danielsson BR, Danielson M, Rundqvist E, Reiland S. 1992. Identical phalangeal defects induced by phenytoin and nifedipine suggest fetal hypoxia and vascular disruption behind phenytoin teratogenicity. Teratology 45:247-258.
9. Danielsson BR, Danielson K, Tomson T. 1995. Phenytoin causes phalangeal hypoplasia in the rabbit fetus at clinically relevant free plasma concentrations. Teratology 52:252-259.
10. Danielsson B, Skold AC, Azarbayjani F, et al. 2000. Pharmacokinetic data support pharmacologically induced embryonic dysrhythmia as explanation for fetal hydantoin syndrome in rats. Toxicol Appl Pharmacol 163:164-175.
11. Gaily E. 1990. Distal phalangeal hypoplasia in children with prenatal phenytoin exposure: results of a controlled anthropometric study. Am J Med Genet 35:574-578.
12. Gelineau-van Waes J, Bennett GD, Finnell RH. 1999. Phenytoin-induced alterations in craniofacial gene expression. Teratology 59:23-34.
13. Hall JG, Froster-Iskenius UG, Allanson JE. 1989. Handbook of normal physical measurements. New York: Oxford University Press. p 178-179.
14. Hanson JW, Smith DW. 1975. The fetal hydantoin syndrome. J Pediatr 87:285-290.
15. Hanson JW, Myrianthopoulos NC, Sedgwick Harvey MA, Smith DW. 1976. Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. J Pediatr 89:662-668.
16. Heltianu C, Costache G, Azibi K, et al. 2002. Endothelial nitric oxide synthase gene polymorphisms in Fabry's disease. Clin Genet 61:423-429.
17. Holmes LB, Harvey EA, Coull BA, et al. 2001. The teratogenicity of anti-convulsant drugs. N Engl J Med 344:1132-1138.
18. Hootnick DR, Packard DR Jr, Levinsohn EM, Wladis A. 1994. A vascular hypothesis for the etiology of club foot. In: Simons GW, editor. The clubfoot: the present and a view of the future. New York: Springer-Verlag. pp 48-59.
19. Hunter AGW. 2000. A pilot study of the possible role of familial defects in anticoagulation as a cause for terminal limb reduction malformations. Clin Genet 57:197-204.
20. Jones KL. 1997. Smith's recognizable patterns of human malformation. 5th ed. Philadelphia: W.B. Saunders Company. pp 744-770.
21. Kay ED, Goldman AS, Daniel JC. 1990. Common biochemical pathway of dysmorphogenesis in murine embryos: use of the glucocorticoid pathway by phenytoin. Teratog Carcinog Mutagen 10:31-39.
22. Kuo CC, Lu L. 1997. Characterization of lamotrigine inhibition of Na+ channels in rat hippocampal neurones. Br J Pharmacol 121:1231-1238.
23. Nakamura K, Nanjyo B. 1992. Congenital skin tube pedicle associated with the constriction band syndrome. Plastic Reconstr Surg 89:746-750.
24. Nulman I, Scolnik D, Chitayat D, et al. 1997. Findings in children exposed in utero to phenytoin and carbamazepine montherapy: independent effects of epilepsy and medications. Am J Med Genet 68:18-24.
25. Rivey MP, Schottelius DD, Berg MJ. 1984. Phenytoin-folic acid: a review. Drug Intell Clin Pharm 18:292-301.
26. Sabry MA, Farag TI. 1996. Hand anomalies in fetal-hydantoin syndrome: from nail/phalangeal hypoplasia to unilateral acheiria. Am J Med Genet 62:410-412.
27. Samren EB, van Duijn CM, Lieve Christiaens GCM, et al. 1999. Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 46:739-746.
28. Taglialatela M, Castaldo P, Pannaccione A, et al. 1998. Human ether-a-go-go related gene (HERG) K+ channels as pharmacological targets. Biochem Pharm 55:1741-1746.
29. Tomson T, Kenneback G. 1997. Arrhythmia, heart rate variability, and antiepileptic drugs. Epilepsia 38:548-551.
30. Van Allen MI. 1981. Fetal vascular disruptions: mechanisms and some resulting birth defects. Pediatr Ann 10:219-233.
31. Wang H, Shi H, Wang Z. 1999. Nicotine depresses the functions of multiple cardiac potassium channels. Life Sci 65:PL143-149.
32. Wells PG, Winn LM. 1996. Biochemical toxicology of chemical teratogenesis. Crit Rev Biochem Mol Biol 31:1-40.